Abeyance (24)
| Date | Circular | Tags | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BSE announces listing of 200 bonus equity shares of Tata Elxsi Ltd that were previously kept in abeyance, effective from September 11, 2025. | |||||||||||||||
BSE announces listing of 200 bonus equity shares of Tata Elxsi Ltd that were previously kept in abeyance, effective from September 11, 2025.
| |||||||||||||||
BSE announces listing of 200 bonus equity shares of Tata Elxsi Ltd kept in abeyance, effective September 11, 2025. | |||||||||||||||
BSE announces listing of 200 bonus equity shares of Tata Elxsi Ltd kept in abeyance, effective September 11, 2025.
| |||||||||||||||
BSE announces listing of 200 bonus equity shares of Tata Elxsi Ltd kept in abeyance, effective September 11, 2025. | |||||||||||||||
BSE announces listing of 200 bonus equity shares of Tata Elxsi Ltd kept in abeyance, effective September 11, 2025.
| |||||||||||||||
BSE announces listing of 100 bonus equity shares of Tata Elxsi Ltd that were kept in abeyance, effective September 10, 2025. | |||||||||||||||
BSE announces listing of 100 bonus equity shares of Tata Elxsi Ltd that were kept in abeyance, effective September 10, 2025.
| |||||||||||||||
BSE announces listing of 100 bonus equity shares of Tata Elxsi Ltd that were kept in abeyance, effective September 10, 2025. | |||||||||||||||
BSE announces listing of 100 bonus equity shares of Tata Elxsi Ltd that were kept in abeyance, effective September 10, 2025.
| |||||||||||||||
BSE announces listing and trading permission for 100 bonus equity shares of Tata Elxsi Ltd kept in abeyance, effective September 10, 2025. | |||||||||||||||
BSE announces listing and trading permission for 100 bonus equity shares of Tata Elxsi Ltd kept in abeyance, effective September 10, 2025.
| |||||||||||||||
BSE lists 1000 bonus equity shares of Ipca Laboratories Ltd kept in abeyance, effective September 01, 2025. | |||||||||||||||
BSE lists 1000 bonus equity shares of Ipca Laboratories Ltd kept in abeyance, effective September 01, 2025.
| |||||||||||||||
BSE permits trading of 1000 bonus equity shares of Ipca Laboratories Ltd kept in abeyance, effective September 1, 2025. | |||||||||||||||
BSE permits trading of 1000 bonus equity shares of Ipca Laboratories Ltd kept in abeyance, effective September 1, 2025.
| |||||||||||||||
BSE permits trading of 1000 bonus equity shares of Ipca Laboratories Ltd kept in abeyance, effective September 1, 2025. | |||||||||||||||
BSE permits trading of 1000 bonus equity shares of Ipca Laboratories Ltd kept in abeyance, effective September 1, 2025.
| |||||||||||||||
BSE announces listing of 1000 bonus equity shares of Ipca Laboratories Ltd kept in abeyance, effective September 1, 2025. | |||||||||||||||
BSE announces listing of 1000 bonus equity shares of Ipca Laboratories Ltd kept in abeyance, effective September 1, 2025.
| |||||||||||||||